Great Novel Therapeutics Biotech & Medicals Corp
TPEX:7427
तय करें कि किस कीमत पर खरीदना आपके लिए उचित होगा। तैयार रहने में हम आपकी मदद करेंगे।
|
G
|
Great Novel Therapeutics Biotech & Medicals Corp
TPEX:7427
|
TW |
|
I
|
ideaForge Technology Ltd
NSE:IDEAFORGE
|
IN |
|
K
|
Kao Corp
XMUN:KAO
|
JP |
|
E
|
Esprinet SpA
F:EP4A
|
IT |
|
S
|
Standard Bank Group Ltd
JSE:SBK
|
ZA |
|
Daimler Truck Holding AG
F:DTG1
|
DE |
|
Verimatrix SA
PAR:VMX
|
FR |
|
FormFactor Inc
NASDAQ:FORM
|
US |
|
N
|
National Australia Bank Ltd
XMUN:NAL
|
AU |
|
A
|
Aon PLC
F:4VK
|
IE |
आंतरिक मूल्य
Great Novel Therapeutics Biotech & Medicals Corp का आंतरिक मूल्य भरोसेमंद ढंग से निकालने के लिए पर्याप्त डेटा नहीं है।
क्या हमारे मूल्यांकन वास्तव में कारगर हैं? बैकटेस्ट के परिणाम देखें .
मौलिक विश्लेषण
Great Novel Therapeutics Biotech & Medicals क्या करती है
Great Novel Therapeutics Biotech & Medicals Corp. engages in the research and development of cancer medical treatment. The company is headquartered in Taipei City, Taipei and currently employs 18 full-time employees. The company went IPO on 2021-07-08. The main product is the oral anti-cancer targeted new drug TM/Kepida, which is mainly used for the treatment of relapsed and refractory peripheral T-cell lymphoma (R/R PTCL) and ER+/Her-2-advanced breast cancer (ER+/Her-2-BC).
- मुख्यालय
- ताइवान TW
- कर्मचारी
- 18
- IPO की तारीख
- जुल. 8, 2021